Sinha Vikas
- SEC CIK
- 0001337845
In the past year, 2 open-market sale filings worth $1.23M and no purchases.
Current role at each company
- SRRK Scholar Rock Holding CorpChief Financial Officeras of Apr 20, 2026
- VRNA Verona Pharma plcDirectoras of Oct 8, 2025
- KLRS Kalaris Therapeutics, Inc.See Remarksas of Feb 24, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.23M
- 2 filings
- Net
- −$1.23M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sinha Vikas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SRRK Scholar Rock Holding Corp
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Sinha VikasChief Financial Officer | SSale | −10.4K | $49.57 | −$516.0K | −1.7%619.9K after | |
| Jan 15, 2026 (view filing) | Jan 13 | 2 days | Sinha VikasChief Financial Officer | SSale | −16.8K | $42.70 | −$715.4K | −2.8%583.2K after |
VRNA Verona Pharma plc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 (view filing) | Aug 1 | 4 days | Sinha VikasDirector | SSale | −4.33K | $13.14 | −$56.9K | −4.4%94.1K after | |
| May 22, 2025 (view filing) | May 20 | 2 days | Sinha VikasDirector | SSale | −160.0K | $9.39 | −$1.50M | −68.2%74.4K after | 10b5-1 |
| May 22, 2025 (view filing) | Apr 29 | 23 days | Sinha VikasDirector | SSale | −160.0K | $8.92 | −$1.43M | −68.2%74.4K after | Amended2 lots10b5-1 |
KLRS Kalaris Therapeutics, Inc.
See Remarks31 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 (view filing) | Feb 21 | 3 days | Sinha VikasSee Remarks | SSale | −303 | $10.08 | −$3.05K | −0.6%49.1K after | |
| Jan 27, 2025 (view filing) | Jan 23 | 4 days | Sinha VikasSee Remarks | SSale | −129 | $9.50 | −$1.23K | −0.3%49.4K after | 2 lots |
| Jan 13, 2025 (view filing)4:15 PM ET | Jan 10 | 3 days | Sinha VikasSee Remarks | SSale | −979 | $0.4401 | −$430.86 | −0.1%1.14M after | |
| Nov 20, 2024 (view filing) | Nov 19 | 1 day | Sinha VikasSee Remarks | SSale | −3.19K | $0.55 | −$1.75K | −0.3%1.14M after | |
| Nov 6, 2024 (view filing) | Nov 5 | 1 day | Sinha VikasSee Remarks | SSale | −5.14K | $0.86 | −$4.42K | −0.4%1.14M after | |
| Oct 23, 2024 (view filing) | Oct 21-22 | 2 days | Sinha VikasSee Remarks | SSale | −3.43K | $0.7745 | −$2.66K | −0.3%1.15M after | 2 lots |
| Oct 4, 2024 (view filing) | Oct 3 | 1 day | Sinha VikasSee Remarks | SSale | −940 | $0.81 | −$761.4 | −0.1%1.15M after | |
| Aug 20, 2024 (view filing) | Aug 19 | 1 day | Sinha VikasSee Remarks | SSale | −3.16K | $0.76 | −$2.40K | −0.3%1.15M after | |
| Aug 7, 2024 (view filing) | Aug 5 | 2 days | Sinha VikasSee Remarks | SSale | −5.25K | $0.73 | −$3.83K | −0.5%1.16M after | |
| Jul 23, 2024 (view filing) | Jul 19-22 | 4 days | Sinha VikasSee Remarks | SSale | −3.40K | $0.7445 | −$2.53K | −0.3%1.16M after | 2 lots |